195 related articles for article (PubMed ID: 18221064)
21. Research into the therapeutic roles of two-pore-domain potassium channels.
Es-Salah-Lamoureux Z; Steele DF; Fedida D
Trends Pharmacol Sci; 2010 Dec; 31(12):587-95. PubMed ID: 20951446
[TBL] [Abstract][Full Text] [Related]
22. Potassium channels as targets for therapeutic intervention.
Garcia ML; Kaczorowski GJ
Sci STKE; 2005 Sep; 2005(302):pe46. PubMed ID: 16174819
[TBL] [Abstract][Full Text] [Related]
23. Potassium channels: gene family, therapeutic relevance, high-throughput screening technologies and drug discovery.
Ford JW; Stevens EB; Treherne JM; Packer J; Bushfield M
Prog Drug Res; 2002; 58():133-68. PubMed ID: 12079199
[TBL] [Abstract][Full Text] [Related]
24. Pharmacology of cardiac potassium channels.
Tamargo J; Caballero R; Gómez R; Valenzuela C; Delpón E
Cardiovasc Res; 2004 Apr; 62(1):9-33. PubMed ID: 15023549
[TBL] [Abstract][Full Text] [Related]
25. K(+) channels as therapeutic drug targets.
Wickenden A
Pharmacol Ther; 2002; 94(1-2):157-82. PubMed ID: 12191600
[TBL] [Abstract][Full Text] [Related]
26. Heteromultimeric delayed-rectifier K+ channels in schwann cells: developmental expression and role in cell proliferation.
Sobko A; Peretz A; Shirihai O; Etkin S; Cherepanova V; Dagan D; Attali B
J Neurosci; 1998 Dec; 18(24):10398-408. PubMed ID: 9852577
[TBL] [Abstract][Full Text] [Related]
27. Ions and blockers in potassium channels: insights from free energy simulations.
Luzhkov VB; Aqvist J
Biochim Biophys Acta; 2005 Feb; 1747(1):109-20. PubMed ID: 15680245
[TBL] [Abstract][Full Text] [Related]
28. Molecular regulation and pharmacology of pacemaker channels.
Bois P; Guinamard R; Chemaly AE; Faivre JF; Bescond J
Curr Pharm Des; 2007; 13(23):2338-49. PubMed ID: 17692005
[TBL] [Abstract][Full Text] [Related]
29. Discovering potassium channel blockers from synthetic compound database by using structure-based virtual screening in conjunction with electrophysiological assay.
Liu H; Gao ZB; Yao Z; Zheng S; Li Y; Zhu W; Tan X; Luo X; Shen J; Chen K; Hu GY; Jiang H
J Med Chem; 2007 Jan; 50(1):83-93. PubMed ID: 17201412
[TBL] [Abstract][Full Text] [Related]
30. Chloride channels in cancer: Focus on chloride intracellular channel 1 and 4 (CLIC1 AND CLIC4) proteins in tumor development and as novel therapeutic targets.
Peretti M; Angelini M; Savalli N; Florio T; Yuspa SH; Mazzanti M
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2523-31. PubMed ID: 25546839
[TBL] [Abstract][Full Text] [Related]
31. The potential therapeutic role of potassium channel modulators in asthma and chronic obstructive pulmonary disease.
Malerba M; Radaeli A; Mancuso S; Polosa R
J Biol Regul Homeost Agents; 2010; 24(2):123-30. PubMed ID: 20487625
[TBL] [Abstract][Full Text] [Related]
32. Voltage-gated K+ channel modulators as neuroprotective agents.
Leung YM
Life Sci; 2010 May; 86(21-22):775-80. PubMed ID: 20385147
[TBL] [Abstract][Full Text] [Related]
33. Potassium channels: new targets in cancer therapy.
Felipe A; Vicente R; Villalonga N; Roura-Ferrer M; Martínez-Mármol R; Solé L; Ferreres JC; Condom E
Cancer Detect Prev; 2006; 30(4):375-85. PubMed ID: 16971052
[TBL] [Abstract][Full Text] [Related]
34. [Potassium ion channels and prostatic diseases].
Guo QK; Liang CZ
Zhonghua Nan Ke Xue; 2005 Jun; 11(6):458-61. PubMed ID: 15999495
[TBL] [Abstract][Full Text] [Related]
35. Targeting ion channels in cancer: a novel frontier in antineoplastic therapy.
Arcangeli A; Crociani O; Lastraioli E; Masi A; Pillozzi S; Becchetti A
Curr Med Chem; 2009; 16(1):66-93. PubMed ID: 19149563
[TBL] [Abstract][Full Text] [Related]
36. Pharmacology of neuronal background potassium channels.
Lesage F
Neuropharmacology; 2003 Jan; 44(1):1-7. PubMed ID: 12559116
[TBL] [Abstract][Full Text] [Related]
37. Targeting cardiac potassium channels for state-of-the-art drug discovery.
Walsh KB
Expert Opin Drug Discov; 2015 Feb; 10(2):157-69. PubMed ID: 25400064
[TBL] [Abstract][Full Text] [Related]
38. Cardiac ATP-sensitive potassium channels: a potential target for an anti-ischaemic pharmacological strategy.
Testai L; Rapposelli S; Calderone V
Cardiovasc Hematol Agents Med Chem; 2007 Jan; 5(1):79-90. PubMed ID: 17266550
[TBL] [Abstract][Full Text] [Related]
39. Potassium channels as pharmacological targets in cardiovascular medicine.
Escande D; Henry P
Eur Heart J; 1993 Jul; 14 Suppl B():2-9. PubMed ID: 8370367
[TBL] [Abstract][Full Text] [Related]
40. Adenosine triphosphate-sensitive potassium (K(ATP)) channel activity is coupled with insulin resistance in obesity and type 2 diabetes mellitus.
Wasada T
Intern Med; 2002 Feb; 41(2):84-90. PubMed ID: 11868613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
